SA, P., DG, G., O, G., GS, G., & A, G. (2022). Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease. Current obesity reports, 11(3), 166. https://doi.org/10.1007/s13679-022-00474-0
Chicago Style (17th ed.) CitationSA, Polyzos, Goulis DG, Giouleme O, Germanidis GS, and Goulas A. "Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease." Current Obesity Reports 11, no. 3 (2022): 166. https://doi.org/10.1007/s13679-022-00474-0.
MLA (9th ed.) CitationSA, Polyzos, et al. "Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease." Current Obesity Reports, vol. 11, no. 3, 2022, p. 166, https://doi.org/10.1007/s13679-022-00474-0.
Warning: These citations may not always be 100% accurate.